TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization

por Thierry, Sylvain, Maadadi, Sarah, Berton, Aurore, Dimier, Laura, Perret, Clémence, Vey, Nelly, Ourfali, Saïd, Saccas, Mathilde, Caron, Solène, Boucard-Jourdin, Mathilde, Colombel, Marc, Werle, Bettina, Bonnin, Marc
Publicado 2023

Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells

por Zhang, Jiang, Le Gras, Stéphanie, Pouxvielh, Kevin, Faure, Fabrice, Fallone, Lucie, Kern, Nicolas, Moreews, Marion, Mathieu, Anne-Laure, Schneider, Raphaël, Marliac, Quentin, Jung, Mathieu, Berton, Aurore, Hayek, Simon, Vidalain, Pierre-Olivier, Marçais, Antoine, Dodard, Garvin, Dejean, Anne, Brossay, Laurent, Ghavi-Helm, Yad, Walzer, Thierry
Publicado 2021